{"date":"2025-12-17","count":21,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4114-2025-12-17-1750-13krrr5","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:50:11","subject":"代重要子公司優良生技醫藥股份有限公司公告114年第一次股東臨時會通過解除新任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-12-17 17:50，「代重要子公司優良生技醫藥股份有限公司公告114年第一次股東臨時會通過解除新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-12-17-1747-uutmnv","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"17:47:28","subject":"公告本公司稽核主管異動","clause":"第11款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-12-17 17:47，「公告本公司稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-12-17-1747-17ygywa","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"17:47:18","subject":"公告本公司財務主管、會計主管、代理發言人異動","clause":"第11款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-12-17 17:47，「公告本公司財務主管、會計主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-12-17-1746-ggk8dv","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"17:46:52","subject":"本公司董事會決議113年第三次限制員工權利新股發行及訂定增資基準日","clause":"第44款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-12-17 17:46，「本公司董事會決議113年第三次限制員工權利新股發行及訂定增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-12-17-1746-1693vso","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"17:46:25","subject":"公告本公司董事會決議召開115年第一次股東臨時會","clause":"第32款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-12-17 17:46，「公告本公司董事會決議召開115年第一次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-12-17-1745-1xihpaj","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:45:50","subject":"代重要子公司優良生技醫藥股份有限公司公告改選董事長","clause":"第6款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-12-17 17:45，「代重要子公司優良生技醫藥股份有限公司公告改選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-12-17-1744-emfdni","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:44:41","subject":"代重要子公司優良生技醫藥股份有限公司公告114年度第一次股東臨時會董監事改選當選名單","clause":"第6款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-12-17 17:44，「代重要子公司優良生技醫藥股份有限公司公告114年度第一次股東臨時會董監事改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-12-17-1737-vrpzlb","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:37:31","subject":"代重要子公司優良生技醫藥股份有限公司公告114年度第一次股東臨時會重要決議事項","clause":"第18款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-12-17 17:37，「代重要子公司優良生技醫藥股份有限公司公告114年度第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-12-17-1713-1oaynm","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-12-17","time":"17:13:13","subject":"本公司受邀參加台新綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-12-17 17:13，「本公司受邀參加台新綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2025-12-17-1707-1y2d1zr","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:07:27","subject":"本公司董事會決議通過113年限制員工權利新股第一次發行名單及股數，並授權董事長訂定增資基準日與後續相關時程","clause":"第53款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2025-12-17 17:07，「本公司董事會決議通過113年限制員工權利新股第一次發行名單及股數，並授權董事長訂定增資基準日與後續相關時程」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-12-17-1704-16sohr8","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-12-17","time":"17:04:35","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-18","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-12-17 17:04，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-12-17-1703-1d102xz","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:03:41","subject":"公告本公司董事會通過向關係人租賃使用權資產","clause":"第20款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-12-17 17:03，「公告本公司董事會通過向關係人租賃使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-12-17-1701-wm9gve","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:01:00","subject":"公告本公司董事會決議擬以私募方式辦理現金增資發行普通股","clause":"第11款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-12-17 17:01，「公告本公司董事會決議擬以私募方式辦理現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-12-17-1700-13zdm3y","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"17:00:34","subject":"公告本公司重要營運主管職務異動","clause":"第8款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-12-17 17:00，「公告本公司重要營運主管職務異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-12-17-1639-1xi94i9","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"16:39:03","subject":"公告本公司舉辦114年第三次線上法說會事宜","clause":"第12款","fact_date":"2025-12-24","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-12-17 16:39，「公告本公司舉辦114年第三次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-12-17-1607-1bj0kjx","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"16:07:24","subject":"公告本公司因配合會計師事務所內部輪調更換會計師。","clause":"第7款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-12-17 16:07，「公告本公司因配合會計師事務所內部輪調更換會計師。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-12-17-1522-1jbk1wn","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"15:22:08","subject":"公告本公司董事會決議發行114年度第一次員工認股權憑證","clause":"第9款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-12-17 15:22，「公告本公司董事會決議發行114年度第一次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-12-17-1519-5rax5d","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-12-17","time":"15:19:57","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-12-17 15:19，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-12-17-1430-dzrh27","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"14:30:15","subject":"代重要子公司潤雅生技股份有限公司公告董事會推選王慧君博士擔任董事長，並兼任總經理","clause":"第6款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-12-17 14:30，「代重要子公司潤雅生技股份有限公司公告董事會推選王慧君博士擔任董事長，並兼任總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-12-17-1347-1je223m","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"13:47:35","subject":"本公司受邀參加國泰證券舉辦之法人說明會，向投資人說明本公司之營運概況、財務及業務相關資訊。","clause":"第12款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-12-17 13:47，「本公司受邀參加國泰證券舉辦之法人說明會，向投資人說明本公司之營運概況、財務及業務相關資訊。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-12-17-0807-1fqukg7","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-12-17","time":"08:07:02","subject":"中裕新藥世界首創長效型雙抗體愛滋病療法TMB-365/TMB-380 Phase 2b臨床試驗完成首位受試者收治(FPI)，全球長效HIV抗體治療邁入關鍵加速期","clause":"第53款","fact_date":"2025-12-17","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-12-17 08:07，「中裕新藥世界首創長效型雙抗體愛滋病療法TMB-365/TMB-380 Phase 2b臨床試驗完成首位受試者收治(FPI」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}